Eventide Asset Management
Investments by market, targeted sectors and preferred funding rounds
Investor Type -
Preferred rounds -
Location
Investments by industry
biotech - 75%
healthtech - 25%
Number of investments: 4
Eventide Asset Management invested in DiCE Molecules during a round worth $80,000,000 - 1/8/2021
Eventide Asset Management invested in Prometheus Biosciences during a round worth $130,000,000 - 11/9/2020
Eventide Asset Management invested in VectivBio during a round worth $110,000,000 - 10/19/2020
Eventide Asset Management invested in Freeline during a round worth $120,000,000 - 7/5/2020